Olema Pharmaceuticals (OLMA) Assets Average (2021 - 2026)

Olema Pharmaceuticals (OLMA) has 6 years of Assets Average data on file, last reported at $532.0 million in Q1 2026.

• On a quarterly basis, Assets Average rose 23.64% year-over-year to $532.0 million in Q1 2026; TTM through Mar 2026 was $532.0 million, a 23.64% increase from a year earlier, with the FY2025 full-year figure at $492.2 million, up 35.24% from the prior year.
• Assets Average for Q1 2026 stood at $532.0 million, up from $442.9 million in the prior quarter.
• Over the last five years, Assets Average for OLMA reached as high as $532.0 million in Q1 2026 and fell as low as $186.7 million in Q2 2023.
• Historically, Assets Average has averaged $306.4 million across 5 years, with a median of $270.3 million in 2024.
• Across the five-year window, Assets Average slipped 29.28% in 2023 and jumped 59.19% in 2025, its largest moves.
• Year by year, Assets Average stood at $223.8 million in 2022, then grew by 27.28% to $284.9 million in 2023, then increased by 19.55% to $340.6 million in 2024, then jumped by 30.06% to $442.9 million in 2025, then grew by 20.11% to $532.0 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $532.0 million in Q1 2026, $442.9 million in Q4 2025, and $367.2 million in Q3 2025.